F18.15
Inhalant abuse with inhalant-induced psychotic disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
Inhalant abuse with inhalant-induced psychotic disorder, classified under ICD-10 code F18.15, refers to a condition where an individual repeatedly uses inhalant substances resulting in serious mental health issues. Inhalants are substances inhaled for their psychoactive effects, but their misuse can lead to profound psychological disturbances, including psychosis. This guide aims to provide a clear, patient-friendly overview of this condition, including its causes, symptoms, diagnosis, and potential treatment options.
Causes & Symptoms
Clinical Causes: Prolonged or repeated inhalant use, often starting in adolescence Use of common household products such as paints, glues, aerosols, and solvents for their psychoactive effects Underlying mental health issues or substance use disorders Environmental factors such as peer pressure or availability of inhalants Genetic predisposition to substance abuse or psychotic disorders
Key Symptoms: Hallucinations, such as hearing voices or seeing things that aren't there Delusional thinking or paranoid ideas Disorganized speech or thoughts Emotional disturbances including agitation, anxiety, or depression Behavioral changes like confusion, hallucinations, or aggression Physical signs such as dizziness, muscle weakness, and tremors during or after inhalant use Withdrawal symptoms upon cessation of inhalants
Diagnostic & Treatment
Diagnosis Path: exclusion of other causes of psychosis, such as primary psychiatric disorders or medical conditions. Laboratory tests and toxicology screenings may support the diagnosis by confirming recent inhalant exposure.
Treatment Protocols: - Long-term follow-up: ongoing support and monitoring to prevent relapse and manage any persistent mental health issues.
Clinical Advice & FAQs
Billing Guidance
Is F18.15 a billable ICD-10 code?
Yes, F18.15 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.15?
Clinical documentation must specify the nature of Inhalant abuse with inhalant-induced psychotic disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference